Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
ABSTRAK
Latar Belakang Transplantasi ginjal telah menjadi pilihan utama terapi bagi pasien dengan penyakit ginjal tahap akhir, baik yang berasal dari donor hidup maupun donor jenazah. Transplantasi ginjal memiliki risiko yang lebih rendah baik untuk mortalitas maupun kejadian kardiovaskular, serta memiliki kualitas hidup yang lebih baik dibandingkan pasien yang menjalani dialisis kronis, baik hemodialisis maupun dialisis peritoneal. Penelitian ini bertujuan mengetahui faktor-faktor yang mempengaruhi kesintasan transplantasi ginjal di RSUPN Ciptomangunkusumo tahun 2010-2017.

Metode Penelitian Desain penelitian ini adalah kohort retrospekstif menggunakan data rekam medis pasien transplantasi ginjal. Sampel penelitian adalah resipien transplantasi ginjal ≥ 18 tahun di di RSUPN Ciptomangunkusumo tahun 2010-2017, yaitu sebanyak 548 pasien.

Hasil penelitian probabilitas kesintasan resipien transplantasi ginjal selama pengamatan 5 tahun adalah 84,1% Hasil analisis dengan regresi cox menunjukkan bahwa resipien dengan donor yang berusia ≥ 40 tahun lebih cepat 1,487 kali untuk meninggal dibandingkan resipien dengan donor yang berusia < 40 tahun, resipien yang berusia ≥ 45 tahun lebih cepat 2,356 kali untuk meninggal dibandingkan pasien yang berusia <45 tahun, lama hemodialisis ≥ 24 bulan lebih cepat 2,356 kali untuk meninggal dibandingkan pasien yang lama hemodialisisnya < 24 bulan, skor charlson > 1 lebih cepat 2,861 kali untuk meninggal dibandingkan pasien yang skor charlson ≤ 1, resipien yang memiliki DM lebih cepat 2,947 kali untuk meninggal dibandingkan dengan yang tidak DM.

Simpulan Kesintasan lima tahun di Indonesia cukup baik. Insiden kematian relatif tinggi, menyebabkan penurunan kelangsungan hidup pasien lima tahun. Namun, hasil keseluruhan masih sebanding dengan negara-negara berkembang lainnya

---

ABSTRACT
Background Kidney transplantation has become the main choice of therapy for patients with end-stage kidney disease, both from living donors and donor bodies. Kidney transplantation has a lower risk for both mortality and cardiovascular events, and has a better quality of life than patients who undergo chronic dialysis, both hemodialysis and peritoneal dialysis. This study aims to determine the factors that influence the survival of kidney transplants in Ciptomangunkusumo Hospital in 2010-2017.

Methods A retrospective cohort study with total consecutive sampling is performed on all kidney transplant recipients in Cipto Mangunkusumo Hospital from March 2019 until May 2019. Data is acquired by analysing medical records and contacting patients directly. Each recipient is followed from the day of transplant until death or december 2018, whichever comes first. Five-year death and patient survival is documented. Kaplan-Meier Curve is used to describe patient survival until the end of study and analysis with Cox regression.

Result which was as many as 548 patients. The results of this study indicate the probability of survival of kidney transplant recommendations during the 5-year observation was 84.1%. The results of the analysis with Cox regression showed that donors aged ≥ 40 years were 1,487 faster to die than recipients with donor aged <40 years, prescriptions aged ≥ 40 years 2,356 times faster to die than patients aged <40 years, duration of hemodialysis ≥ 24 months faster 2,356 times to die compared to patients with long hemodialysis <24 months, Charles score> 1 faster 2,861 times to die than patients who score charlson ≤ 1, the recipients who have DM are 2.97 times faster to die compared to those without DM .

Conclusions The outcome of five-year death in Indonesia is very satisfactory. The incidence of death is relatively high, causing a decline in five-year patient survival. However, the overall results are still comparable to other developing countries.

Abstrak :
[ABSTRAK
Hemodialisis merupakan terapi modalitas yang digunakan pada pasien gagal ginjal terminal untuk memperpanjang kehidupan. Tolok ukur keberhasilan dalam memperpanjang kehidupan pasien melihat survival rate. Penelitian ini bertujuan untuk mengetahui faktor-faktor yang mempengaruhi Survival rate pada pasien yang mendapatkan terapi hemodialisis dalam 5 tahun. Penelitian ini menggunakan desain analitik korelasi dengan pendekatan retrospektif dan melibatkan 114 orang pasien yang memulai menjalani terapi hemodialisis dari tahun 2010 sampai bulan Juni tahun 2015 saat pengambilan data serta pengumpulan data dilakukan dengan studi dokumentasi melalui laporan harian ruangan hemodialisa. Sebanyak 86,8 % pasien mengalami event. Kepatuhan program hemodialisis dan dosis hemodialisis dapat mempengaruhi survival rate. Pasien yang tidak patuh menjalani program hemodialisis memiliki risiko 4,844 kali mengalami event dan pasien yang tidak sesuai dosis dalam menjalani terapi hemodialisis memiliki risiko 25,188 kali lebih mengalami event. Penelitian ini dapat memberikan dampak positif dalam meningkatkan kuwalitas pelayanan keperawatan khususnya dalam menekan angka event pada pasien yang menjalani terapi hemodialisis sehingga pasien akan survival dengan terapi hemodialisis dan diharapkan pada peneliti selanjutnya untuk melanjutkan penelitian survival rate pada pasien hemodialisis dengan melihat variabel kepatuhan pembatasan cairan dan nutrisi pada pasien hemodialisis.

---

ABSTRACT
Hemodialysis is a modality treatment used in patients with terminal renal failure to prolong their lives. Benchmark of success in prolonging lives of patients is indicated by survival rate. This study aimed to identify the factors that influence survival rate in patients receiving hemodialysis therapy within 5 years. This study used analytical correlation with retrospective approach and involving 114 patients from 2010 to June 2015. Data collection was conducted by study documentation through daily reports of hemodialysis unit. Most of patients 86.8% experienced an event. Compliance in hemodialysis program and hemodialysis dose may affect survival rate. Non-adherent patients undergoing hemodialysis had 4.844 times higher risk of experiencing an event. Patients who did not fit in the dose of hemodialysis therapy has 25.188 times higher risk of experiencing an event. This research may have a positive impact in improving the quality of nursing care services, especially in suppressing the number of events in patients undergoing hemodialysis. It is expected that further research to assess variables such as compliance of fluids restriction and nutrition in hemodialysis patients., Hemodialysis is a modality treatment used in patients with terminal renal failure to prolong their lives. Benchmark of success in prolonging lives of patients is indicated by survival rate. This study aimed to identify the factors that influence survival rate in patients receiving hemodialysis therapy within 5 years. This study used analytical correlation with retrospective approach and involving 114 patients from 2010 to June 2015. Data collection was conducted by study documentation through daily reports of hemodialysis unit. Most of patients 86.8% experienced an event. Compliance in hemodialysis program and hemodialysis dose may affect survival rate. Non-adherent patients undergoing hemodialysis had 4.844 times higher risk of experiencing an event. Patients who did not fit in the dose of hemodialysis therapy has 25.188 times higher risk of experiencing an event. This research may have a positive impact in improving the quality of nursing care services, especially in suppressing the number of events in patients undergoing hemodialysis. It is expected that further research to assess variables such as compliance of fluids restriction and nutrition in hemodialysis patients.]

Abstrak :
Latar Belakang: Kanker serviks menduduki peringkat ke tiga di seluruh dunia sebagaipenyebab kematian perempuan dan merupakan penyebab kematian utama perempuan dinegara berkembang. Diperlukan evaluasi kesintasan berkala yang secara tidak langsungmenjadi cermin tatalaksana. Tujuan: Mengetahui kesintasan pasien kanker serviks di RSCM. Metode: Penelitian ini menggunakan desain kohort retrospektif terhadap data rekammedis pasien kanker serviks pada tahun 2012-2014 dengan metode total populationsampling. Analisis data dilakukan menggunakan kurva Kaplan Meier, uji Log Rank dan Regresi Cox untuk mencari kemaknaan hubungan antarvariabel. Hasil: Terdapat 1.303 subjek penelitian dengan angka kesintasan kanker serviks hingga tahun ke-5 sebesar 76%, 66%, 60%, 43% dan 36% dengan median kesintasan sebesar 1355 hari secara keseluruhan. Terdapat perbedaan hazard bermakna pada variabel stadium kanker (p<0,001). Analisis regresi cox menunjukkan faktor yang berpengaruh terhadap kesintasan adalah stadium kanker. Kesimpulan: Kesintasan 5 tahun kanker serviks di RSCM tahun 2012-2014 sebesar 36%.

---

Background: Cervical cancer is ranked third as female cause of death worldwide and isthe leading cause of death of women in developing countries. A periodic survivalevaluation is required that implies the treatment implicitly. Objective: To know the survival rate of cervical cancer patients at CiptoMangunkusumo Hospital. Methods: This retrospective cohort study used medical records data of cervical cancerpatients in 2012- 2014 using total population sampling method. Data analysis was doneusing Kaplan Meier curve, Rank Log test and Cox Regression to find the associationbetween variables. Results: There were 1.303 subjects with overall kesintasan rates of cervical cancer up tothe fifth year of 76, 66, 60, 43 dan 36 with a median survival 1355 days. There were significant hazard differences in cancer stage variables (p <0.001). Cox regression analysis showed that factors affecting survival were cancer stage. Conclusion: The 5-year kesintasan rate of cervical cancer at Cipto Mangunkusumo hospital in 2012-2014 is 36%.

Abstrak :
Latar Belakang Pada tahun 2020, ditemukan total kasus kanker serviks mencapai 36.633 kasus dengan 21.003 di antaranya adlaah kasus kematian di Indonesia. Pasien kanker serviks stadium awal diberikan pilihan tatalaksana pembedahan umumnya berupa histerektomi. Pilihan terapi ajuvan juga diberikan guna mengurangi risiko terjadinya kekambuhan. Dengan tingginya kasus kematian kanker serviks di Indonesia, diperlukan penelitian lebih lanjut terkait angka kesintasan pasien kanekr serviks yang dilakukan histerektomi radikal di Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo pada tahun 2010-2018 dengan memerhatikan dilakukan atau tidaknya terapi ajuvan dan ada tidaknya kekambuhan yang terjadi pada pasien. Metode Penelitian ini adalah penelitian deskriptif analitik dengan desain penelitian kohort retrospektif. Data diambil dari rekam medik dan dianalisis kesintasannya dengan metode Kaplan-Meier. Hasil Didapat sebanyak 9,1% (7 orang) pasien mengalami kematian (event) dan 90,9% (70 orang) pasien bertahan hidup dalam kurun waktu tiga tahun dari tanggal tatalaksana histerektomi radikal dilakukan. Pada analisis bivariat antara variabel usia, stadium, terapi ajuvan, dan kekambuhan terhadap kesintasan tidak ditemukan adanya P Value < 0,05 sehingga tidak ada perbedaan ataupun hubungan yang bermakna. Kesimpulan Kesintasan tiga tahun pasien kanker serviks yang dilakukan histerektomi radikal di Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo pada tahun 2010-2018 sebesar 90,9%. ......Introduction In 2020, the total number of cervical cancer cases was found to reach 36,633 cases with 21,003 of them being deaths in Indonesia. Patients with early stage cervical cancer are given surgical treatment options, generally in the form of hysterectomy. Adjuvant therapy options are also given to reduce the risk of recurrence. With the high number of cervical cancer deaths in Indonesia, further research is needed regarding the survival rate of cervical cancer patients who undergo radical hysterectomy in National Referral Hospital Cipto Mangunkusumo in 2010-2018 by paying attention to whether or not adjuvant therapy was carried out and whether or not there was a recurrence. Method This research is a descriptive analytical study and using a retrospective cohort design. Data were taken from medical records and analyzed for survival using the Kaplan-Meier method. Results It is found that 9.1% (7 people) of patients experienced death (event) and 90.9% (70 people) of patients survived within three years from the date the radical hysterectomy was carried out. In the bivariate analysis between the variables such as age, stage, adjuvant therapy, and recurrence, there is no P value < 0.05 was found (no significant difference). Conclusion Three-year survival of cervical cancer patients who undergo radical hysterectomy in National Referral Hospital Cipto Mangunkusumo in 2010-2018 was 90.9%.

Abstrak :
ABSTRAK
Latar Belakang Leukemia limfoblastik akut LLA adalah keganasan paling sering pada anak di sebagian besar dunia insiden bervariasi di berbagai daerah mulai 15 sampai 40 Keberhasilan pengobatan pada LLA dapat dilihat berdasarkan angka kesintasan Rumah Sakit Sanglah telah merawat pasien leukemia anak akan tetapi sampai saat ini belum pernah dilakukan penilaian terhadap kesintasan pada kasus leukemia akut Tujuan Untuk mengetahui angka kesintasan pasien LLA serta faktor faktor yang memengaruhi LLA di bawah umur 12 tahun di RSUP Sanglah dari tahun 2010 2012 Metode Penelitian kohort retrospektif dilakukan di RS Sanglah dengan menggunakan data sekunder dari catatan medis pasien LLA dari Januari 2010 ndash Desember 2012 Sampel adalah pasien berusia 0 12 tahun terdiagnosis LLA kemudian dikelompokkan menjadi risiko biasa dan risiko tinggi berdasarkan nilai leukosit awal usia dan protokol LLA tahun 2006 Hasil Penelitian Terdapat 33 subjek pasien LLA Didapatkan perbedaan bermakna faktor prognostik usia 1 9 tahun dengan usia 9 tahun dan jumlah leukosit 50 000 mL dengan leukosit 50 000 mL memengaruhi angka kesintasan dengan nilai masing masing p 0 023 dan p 0 013 Angka kesintasan hidup secara keseluruhan pasien LLA adalah 30 3 didapatkan perbedaan bermakna angka kesintasan antara RT dan RB dengan nilai masing masing adalah 11 8 43 8 dan p ABSTRACT
Background Acute lymphoblastic leukemia ALL is the most common hildhood cancer in the world Incidence rate found various in several countries from 15 to 40 A successful theraphy of ALL be evaluated by the survival rate Sanglah hospital has been treated children with ALL but however a research of survival rate in children with ALL has never been done before Objective To know the survival rate of children with ALL and factors that affect ALL in children under 12 years old that has been treated in Sanglah Hospital from 2010 2012 Method A retrospective cohort study run in Sanglah Hospital using secondary data from medical record of children with ALL between January 2010 December 2012 Sample is ALL patients aged 0 12 years old with diagnosis ALL will be separated into normal risk group and high risk group based on early number of leucosyte age and therapy protokol year 2006 Results There are 33 subjects of children with ALL Significant difference of prognostic factors were found between the age of 1 9 years old and at the age 9 years old as well as between leucocyte count 50 000 mL and those with leucocyte count 50 000 mL affect the survival rate with each p value of p 0 023 and p 0 013 The Overall survival rate of ALL patients was 30 3 There were significant difference of survival rate between RT and RB valued 11 8 43 8 with p;Background Acute lymphoblastic leukemia ALL is the most common hildhood cancer in the world Incidence rate found various in several countries from 15 to 40 A successful theraphy of ALL be evaluated by the survival rate Sanglah hospital has been treated children with ALL but however a research of survival rate in children with ALL has never been done before Objective To know the survival rate of children with ALL and factors that affect ALL in children under 12 years old that has been treated in Sanglah Hospital from 2010 2012 Method A retrospective cohort study run in Sanglah Hospital using secondary data from medical record of children with ALL between January 2010 December 2012 Sample is ALL patients aged 0 12 years old with diagnosis ALL will be separated into normal risk group and high risk group based on early number of leucosyte age and therapy protokol year 2006 Results There are 33 subjects of children with ALL Significant difference of prognostic factors were found between the age of 1 9 years old and at the age 9 years old as well as between leucocyte count 50 000 mL and those with leucocyte count 50 000 mL affect the survival rate with each p value of p 0 023 and p 0 013 The Overall survival rate of ALL patients was 30 3 There were significant difference of survival rate between RT and RB valued 11 8 43 8 with p;Background Acute lymphoblastic leukemia ALL is the most common hildhood cancer in the world Incidence rate found various in several countries from 15 to 40 A successful theraphy of ALL be evaluated by the survival rate Sanglah hospital has been treated children with ALL but however a research of survival rate in children with ALL has never been done before Objective To know the survival rate of children with ALL and factors that affect ALL in children under 12 years old that has been treated in Sanglah Hospital from 2010 2012 Method A retrospective cohort study run in Sanglah Hospital using secondary data from medical record of children with ALL between January 2010 December 2012 Sample is ALL patients aged 0 12 years old with diagnosis ALL will be separated into normal risk group and high risk group based on early number of leucosyte age and therapy protokol year 2006 Results There are 33 subjects of children with ALL Significant difference of prognostic factors were found between the age of 1 9 years old and at the age 9 years old as well as between leucocyte count 50 000 mL and those with leucocyte count 50 000 mL affect the survival rate with each p value of p 0 023 and p 0 013 The Overall survival rate of ALL patients was 30 3 There were significant difference of survival rate between RT and RB valued 11 8 43 8 with p

Abstrak :
This research hrld in Breeding Laboratory faculty of Agriculture of Dr, Soetomo University Surabaya,during 15 days from 15 th November through 1 st December 2004.......

Abstrak :
ABSTRACT
Background: cervical cancer is the third leading cause of female deaths worldwide, and it is the leading cause of female deaths in developing countries. A routine survival evaluation is required to imply the result of the treatment. The aim of this study was to determine the cervical cancer patient survival rate at the Cipto Mangunkusumo hospital as national referral hospital in Indonesia. Methods: our retrospective cohort study utilized the medical records of cervical cancer patients from 2012 to 2014 using total population sampling method. The data analysis was conducted using the Kaplan-Meier curve, log rank test and Cox regression to determine significant associations between variables. Results: there were 1,303 subjects with overall survival rates of cervical cancer up to the fifth year of 76%, 65%, 59%, 43% and 34%, respectively, with a median survival of 1,316 days. There were significant differences of hazard ratio for cancer stage variables (p<0.001), and the Cox regression analysis showed that the factor affecting survival was cancer stage. Conclusion: the 5-year cervical cancer survival rate at the Cipto Mangunkusumo hospital from 2012 to 2014 was 34%.

Abstrak :
Pendahuluan dan tujuan: Kanker kandung kemih ditandai dengan tingkat rekurensi dan progresivitas yang tinggi. E-cadherin berfungsi sebagai salah satu molekul terpenting yang mengambil bagian dalam aderensi sel-sel epitel, menunjukkan penghambatan perkembangan sel tumor. Penelitian ini bertujuan untuk mengetahui hubungan antara ekspresi E-cadherin dengan progresivitas kanker kandung kemih selama 3 tahun. Metode: Penelitian ini merupakan penelitian kohort retrospektif yang melibatkan pasien kanker kandung kemih di Rumah Sakit Cipto Mangunkusumo, Jakarta. Diagnosis kanker kandung kemih dikonfirmasi oleh pemeriksaan histopatologi dan imunohistokimia antara 2011-2018, dengan penilaian dan stadium ditentukan oleh ahli uropatolog dan urolog onkologi. E-cadherin diperiksa melalui pemeriksaan imunohistokimia pada saat diagnosis. Data demografi, invasi jaringan otot, stadium klinis, derajat, metastasis, multifokal, dan kekambuhan diperoleh dari rekam medis dan laporan patologis. Hubungan ekspresi E-cadherin dengan invasi otot dan kanker kandung kemih invasi non-muskuler dievaluasi dan dianalisis secara statistik. Data kelangsungan hidup pasien ditindaklanjuti melalui komunikasi telepon. Hasil: Empat puluh pasien kanker kandung kemih dengan usia rata-rata 60,05 ± 10,3 tahun menjadi subyek penelitian. Sebagian besar subjek memiliki ekspresi E-cadherin yang tinggi (85%), invasi otot (65%), derajat tinggi (65%), tanpa metastasis (87,5%), multifokal (65%), tanpa rekurensi (62,5%). Ekspresi E-cadherin yang lebih rendah diasosiasikan dengan stadium klinis kanker kandung kemih yang lebih tinggi (p <0,02) dan metastasis (p <0,001). Pasien dengan ekspresi E-cadherin rendah menunjukkan kelangsungan hidup kumulatif yang lebih buruk daripada yang tinggi (rata-rata 32 bulan vs 25 bulan, p = 0,13). Kesimpulan: Kadar E-cadherin yang rendah dikaitkan dengan risiko invasi otot yang lebih tinggi, stadium klinis, derajat histologis, dan risiko metastasis. Sementara itu, pasien dengan tingkat E-cadherin yang tinggi menunjukkan tingkat kelangsungan hidup tiga tahun yang lebih baik. ......Introduction: Bladder cancer is characterized with high recurrence and progressivity. E-cadherin serves as one of the most important molecules partaking in the epithelial cells cell-to-cell adherence, suggested to inhibit tumor cells progression. This study aims to investigate the association between the E-cadherin expressions with bladder cancer progressiveness in 3 years. Methods: This study was a retrospective cohort study involving bladder cancer patients in Cipto Mangunkusumo Hospital, Jakarta. Diagnosis of bladder cancers confirmed by histopathological and immunohistochemistry examination between 2011–2018, with both grading and staging determined by uropathologists and uro-oncologists. E-cadherin was examined through immunohistochemistry examination at the time of diagnosis. Data on demography, muscle invasion, clinical staging, grade, metastasis, multifocality, and recurrence were obtained from medical records and pathology reports. The association of E-cadherin expression to muscle invasion and non-muscle invasion bladder cancer was evaluated and statistically analyzed. Patients survival data were followed up by phone. Results: Forty bladder cancer patients with mean age of 60.05 ± 10.3 years were included. Most subjects had high E-cadherin expression (85%), muscle invasion (65%), high grade (65%), no metastasis (87.5%), multifocality (65%), no recurrence (62.5%). Lower expression of E-cadherin was associated with higher clinical stage (p <0.02) and metastasis (p <0.001). Patients with low E-cadherin expression showed worse cumulative survival than the high one (mean 32 months vs 25 months, p = 0.13). Conclusion: Low level of E-cadherin was associated with higher risk in muscle invasion, clinical staging, histological grade and risk of metastasis. Meanwhile, patients with high level of E-cadherin showed better three-year survival rate